Biotech 2050 Podcast
Mobilizing the immune system to combat disease, Liang Schweizer, Founder & CEO, HiFiBiO Tx
about a year ago
BIO Special: New vision for immunotherapy, Detlev Biniszkiewicz, Founder & CEO, NextPoint Tx
about a year ago
BIO Special: Advancing kidney disease care, Eric Dobmeier, President & CEO, Chinook Tx
about a year ago
BIO Special: Advancing heart disease treatment, Faraz Ali, CEO, Tenaya Therapeutics
about a year ago
Drugging the undruggable with Gregory Verdine, Co-Founder, President & CEO, Lifemine Tx & FogPharma
about a year ago
Pioneering precision therapies for cancer & blood disorders, Kate Haviland, CEO, Blueprint Medicines
about a year ago
Targeting highly dynamic proteins to develop precision medicines, Asit Parikh, Pres. & CEO, MOMA Tx
about a year ago
RNA-guided programmable therapeutics for fibrosis, Samir Ounzain, CEO & Co-Founder, HAYA Tx
about a year ago